asset sales
AxoSim acquires Vyant’s organoid tech for brain disorder research
Anika Sharma
AxoSim, a New Orleans-based drug discovery biotech, has successfully completed the acquisition of the neuroscience research assets from Vyant Bio’s ...
Kanvas Bio emerges from Federation’s demise with clinical-stage assets
Anika Sharma
In a strategic move, Kanvas Biosciences has seized the opportunity to acquire key assets from Federation Bio, a biotech company, ...
